This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (311) Malaria Surveillance and Prevention (26)

Published on in Vol 9, No 11 (2020): November

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/20904, first published .
Mass Drug Administration With High-Dose Ivermectin and Dihydroartemisinin-Piperaquine for Malaria Elimination in an Area of Low Transmission With High Coverage of Malaria Control Interventions: Protocol for the MASSIV Cluster Randomized Clinical Trial

Mass Drug Administration With High-Dose Ivermectin and Dihydroartemisinin-Piperaquine for Malaria Elimination in an Area of Low Transmission With High Coverage of Malaria Control Interventions: Protocol for the MASSIV Cluster Randomized Clinical Trial

Mass Drug Administration With High-Dose Ivermectin and Dihydroartemisinin-Piperaquine for Malaria Elimination in an Area of Low Transmission With High Coverage of Malaria Control Interventions: Protocol for the MASSIV Cluster Randomized Clinical Trial

Authors of this article:

Edgard Diniba Dabira1 Author Orcid Image ;   Harouna M Soumare1 Author Orcid Image ;   Steven W Lindsay2 Author Orcid Image ;   Bakary Conteh1 Author Orcid Image ;   Fatima Ceesay1 Author Orcid Image ;   John Bradley3 Author Orcid Image ;   Christian Kositz3 Author Orcid Image ;   Henk Broekhuizen4 Author Orcid Image ;   Balla Kandeh5 Author Orcid Image ;   Alexandra E Fehr6, 7 Author Orcid Image ;   Claudia Nieto-Sanchez6 Author Orcid Image ;   Joan Muela Ribera8 Author Orcid Image ;   Koen Peeters Grietens6 Author Orcid Image ;   Menno Roderick Smit9, 10 Author Orcid Image ;   Chris Drakeley3 Author Orcid Image ;   Teun Bousema4 Author Orcid Image ;   Jane Achan1 Author Orcid Image ;   Umberto D’Alessandro1 Author Orcid Image
Article Authors Cited by (13) Tweetations (7) Metrics

Journals

  1. Pessanha de Carvalho L, Kreidenweiss A, Held J. Drug Repurposing: A Review of Old and New Antibiotics for the Treatment of Malaria: Identifying Antibiotics with a Fast Onset of Antiplasmodial Action. Molecules 2021;26(8):2304 View
  2. Fehr A, Nieto-Sanchez C, Muela J, Jaiteh F, Ceesay O, Maneh E, Baldeh D, Achan J, Dabira E, Conteh B, Bunders-Aelen J, Smekens T, Broekhuizen H, D’Alessandro U, Peeters Grietens K. From informed consent to adherence: factors influencing involvement in mass drug administration with ivermectin for malaria elimination in The Gambia. Malaria Journal 2021;20(1) View
  3. Kositz C, Bradley J, Hutchins H, Last A, D'Alessandro U, Marks M. Broadening the range of use cases for ivermectin – a review of the evidence. Transactions of The Royal Society of Tropical Medicine and Hygiene 2022;116(3):201 View
  4. Rasmussen C, Alonso P, Ringwald P. Current and emerging strategies to combat antimalarial resistance. Expert Review of Anti-infective Therapy 2022;20(3):353 View
  5. Hernandez Maldonado J, Grundmann O. Drug‐Drug Interactions of Artemisinin‐Based Combination Therapies in Malaria Treatment: A Narrative Review of the Literature. The Journal of Clinical Pharmacology 2022;62(10):1197 View
  6. Wu L, Hsiang M, Prach L, Schrubbe L, Ntuku H, Dufour M, Whittemore B, Scott V, Yala J, Roberts K, Patterson C, Biggs J, Hall T, Tetteh K, Gueye C, Greenhouse B, Bennett A, Smith J, Katokele S, Uusiku P, Mumbengegwi D, Gosling R, Drakeley C, Kleinschmidt I. Serological evaluation of the effectiveness of reactive focal mass drug administration and reactive vector control to reduce malaria transmission in Zambezi Region, Namibia: Results from a secondary analysis of a cluster randomised trial. eClinicalMedicine 2022;44:101272 View
  7. Fehr A, Muela J, Nieto-Sanchez C, Manneh E, Baldeh D, Ceesay O, Bardají A, Zuiderent-Jerak T, Bunders-Aelen J. The role of social cohesion in the implementation and coverage of a mass drug administration trial for malaria control in the Gambia: An in-depth comparison of two intervention villages. Social Science & Medicine 2021;291:114487 View
  8. Fehr A, Nieto-Sanchez C, Muela J, Manneh E, Baldeh D, Ceesay O, D’Alessandro U, Dabira E, Kingori P, Peeters Grietens K, Bardají A, Bunders-Aelen J, Zuiderent-Jerak T. Doing ‘reciprocity work’: The role of fieldworkers in a mass drug administration trial in the Gambia. Global Public Health 2022;17(12):4116 View
  9. Dabira E, Soumare H, Conteh B, Ceesay F, Ndiath M, Bradley J, Mohammed N, Kandeh B, Smit M, Slater H, Peeters Grietens K, Broekhuizen H, Bousema T, Drakeley C, Lindsay S, Achan J, D'Alessandro U. Mass drug administration of ivermectin and dihydroartemisinin–piperaquine against malaria in settings with high coverage of standard control interventions: a cluster-randomised controlled trial in The Gambia. The Lancet Infectious Diseases 2022;22(4):519 View
  10. Soumare H, Dabira E, Camara M, Jadama L, Gaye P, Kanteh S, Jawara E, Njie A, Sanneh F, Ndiath M, Lindsay S, Conteh B, Ceesay S, Mohammed N, Ooko M, Bradley J, Drakeley C, Erhart A, Bousema T, D’Alessandro U. Entomological impact of mass administration of ivermectin and dihydroartemisinin-piperaquine in The Gambia: a cluster-randomized controlled trial. Parasites & Vectors 2022;15(1) View
  11. Wu L, Hsiang M, Prach L, Schrubbe L, Ntuku H, Kang Dufour M, Whittemore B, Scott V, Yala J, Roberts K, Patterson C, Biggs J, Hall T, Tetteh K, Smith Gueye C, Greenhouse B, Bennett A, Smith J, Katokele S, Uusiku P, Mumbengegwi D, Gosling R, Drakeley C, Kleinschmidt I. Serological Evaluation of a Cluster Randomised Trial on the Use of Reactive Focal Mass Drug Administration and Reactive Vector Control to Reduce Malaria Transmission in Zambezi Region, Namibia. SSRN Electronic Journal 2021 View
  12. Muela Ribera J. Dinámicas sociales y acoplamiento estructural: dos elementos clave, pero a menudo olvidados, de la participación comunitaria en los proyectos de Salud Global. Revista de Antropología Social 2023;32(2):155 View
  13. Kositz C, Vasileva H, Mohammed N, Achan J, Dabira E, D’Alessandro U, Bradley J, Marks M. Risk factors for non-participation in ivermectin and dihydroartemisinin-piperaquine mass drug administration for malaria control in the MASSIV trial. Malaria Journal 2024;23(1) View